This might stem from the fact that the mentioned meta-analysis study investigated the protein expression of CD133 rather than the mRNA expression of CD133. Despite the scarcity of cancer stem cells in tumor bulk, recent advances in single-cell sequencing approaches have provided ample opportunities to study their genetic properties. The gene discussed is PROM1; the disease is cancer.